3M (MMM)
(Delayed Data from NYSE)
$96.35 USD
+0.81 (0.85%)
Updated May 8, 2024 04:00 PM ET
After-Market: $96.35 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
D Value A Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$96.35 USD
+0.81 (0.85%)
Updated May 8, 2024 04:00 PM ET
After-Market: $96.35 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
D Value A Growth B Momentum B VGM
Zacks News
Conglomerate 3M’s focus on business transformation — with moves like the localization of decision making and integration of supply chains — enhances its competitive advantage. Also, its recognized product brands and investments in innovation are compelling. Inorganic actions (buyouts and divestments) are added advantages. Acelity, bought in October 2019, is predicted to aid 3M’s medical solutions business. Being one of the largest manufacturers of respiratory masks, the coronavirus outbreak has added to the company’s growth potential.
3M (MMM) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
3M (MMM) closed the most recent trading day at $163.90, moving -1.68% from the previous trading session.
General Electric Reopens Debt Offerings, Grabs Turbine Deal
by Zacks Equity Research
General Electric's (GE) reopening of previous debt offerings will likely allow it to improve its liquidity position. Also, it clinches a gas turbine upgrade project from JFE in Japan.
Honeywell (HON) to Test Advanced T55 Engine for Helicopters
by Zacks Equity Research
Honeywell's (HON) modernized T55 engine will allow its operators to maintain lower maintenance costs, while improving its performance and serviceability.
3M (MMM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, 3M (MMM) closed at $162.55, marking a +0.83% move from the previous day.
The Zacks Analyst Blog Highlights: Alibaba, UnitedHealth, Merck, PetroChina and 3M
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Alibaba, UnitedHealth, Merck, PetroChina and 3M
3M's (MMM) Solid Product Portfolio to Aid Amid Pandemic
by Zacks Equity Research
3M (MMM) faces risks from the pandemic-related uncertainties, evident from a sales decline in April. However, cost-reduction measures and huge demand for respirators will likely support results in the second quarter.
Top Stock Reports for Alibaba, UnitedHealth & Merck
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group (BABA), UnitedHealth (UNH) and Merck (MRK).
The Zacks Analyst Blog Highlights: Exxon Mobil, Verizon Communications, Chevron, Pfizer and 3M Company
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Exxon Mobil, Verizon Communications, Chevron, Pfizer and 3M Company
5 Dogs of the Dow for the Month of June
by Tirthankar Chakraborty
Dogs of the Dow have large customer base, sustainable business model, a long track of profitability and strong liquidity, which allow them to offer sizable yields regardless of market conditions.
3M (MMM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
3M (MMM) closed the most recent trading day at $156.44, moving -0.24% from the previous trading session.
3M (MMM) Up 1.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
3M (MMM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Diversified Operations Industry Outlook Bleak on Coronavirus Woes
by Payal Jalan
The pandemic's adverse impacts on multiple end markets, especially commercial aerospace, general industrial and others, hurt the diversified operations industry's prospects. However, pandemic-induced demand for many products might aid.
General Electric's (GE) Unit Receives Wind Turbine Contract
by Zacks Equity Research
General Electric's (GE) Renewable Energy to soon deliver 38 units of 2.7-132 onshore wind turbines to Powerica. A healthy relationship with Powerica might benefit going forward.
General Electric Takes Multiple Debt Restructuring Actions
by Zacks Equity Research
General Electric (GE) completes and announces the results of its debt tender offerings for U.S. Dollar, Euro and GBP denominated notes. Also, GE Capital closes its debt offerings.
The Zacks Analyst Blog Highlights: SAP, Thermo Fisher, TOTAL, 3M and FIS
by Zacks Equity Research
The Zacks Analyst Blog Highlights: SAP, Thermo Fisher, TOTAL, 3M and FIS
Danaher's Stock Offering Proceeds to Fund Corporate Needs
by Zacks Equity Research
Danaher (DHR) completes the offering of common and convertible preferred shares. It intends on using the funds raised to pay for its corporate needs.
Top Stock Analyst Reports for SAP, Thermo Fisher & TOTAL
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including SAP SE (SAP), Thermo Fisher Scientific (TMO) and TOTAL (TOT).
Can Industrial ETFs Gain Post Mixed Q1 Earnings?
by Sweta Jaiswal, FRM
We discuss the impact of Q1 earnings releases of some major players on industrial ETFs with heavy exposure to the same.
Face Mask Production Saving Retailers Amid Coronavirus
by Ritujay Ghosh
A number of apparel brands are not only supplementing for the shortage of protective gear but also looking for a survival strategy by selling facial masks and other protective gear.
Danaher (DHR) Beats Q1 Earnings Estimates, Provides Bleak View
by Zacks Equity Research
Danaher's (DHR) Q1 results reflect healthy growth in organic sales and the impacts of forex woes. Core sales in Q2 are expected to reflect the pandemic woes and gains from Cytiva.
Trump Pushes for US-Made Medical Products: 4 Winners
by Ritujay Ghosh
An executive order to address the lack of medical product manufacturing in the United States could in a way boost manufacturing and sales of home-grown goods.
Company News for Apr 29, 2020
by Zacks Equity Research
Companies In The News Are: MMM, PEP, CNC, SIRI.
The Zacks Analyst Blog Highlights: Visa, Novo Nordisk, American Tower, Caterpillar and 3M
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Visa, Novo Nordisk, American Tower, Caterpillar and 3M
Earnings Data Deluge
by Zacks Equity Research
Earnings Data Deluge
A Plethora of Q1 Earnings Results: MMM, CAT, PEP & More
by Mark Vickery
A big morning for Q1 earnings reports joins a new Advance Trade in Goods report out this morning. Pre-market indexes are way in the green at this hour.